AGAPE ATP CORPORATION COMMON STOCK
NASDAQ: ATPC (Agape ATP Corporation)
Last update: 3 minutes ago1.35
-0.62 (-31.47%)
| Previous Close | 1.97 |
| Open | 1.48 |
| Volume | 1,239,797 |
| Avg. Volume (3M) | 1,589,561 |
| Market Cap | 5,385,231 |
| Price / Sales | 3.84 |
| Price / Book | 1.96 |
| 52 Weeks Range | |
| Earnings Date | 31 Mar 2025 - 4 Apr 2025 |
| Profit Margin | -178.07% |
| Operating Margin (TTM) | -144.90% |
| Diluted EPS (TTM) | -0.730 |
| Quarterly Revenue Growth (YOY) | 3.00% |
| Total Debt/Equity (MRQ) | 11.00% |
| Current Ratio (MRQ) | 4.72 |
| Operating Cash Flow (TTM) | -2.92 M |
| Levered Free Cash Flow (TTM) | -2.00 M |
| Return on Assets (TTM) | -50.83% |
| Return on Equity (TTM) | -121.61% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Packaged Foods (US) | Mixed | Mixed |
| Packaged Foods (Global) | Mixed | Mixed | |
| Stock | Agape ATP Corporation | - | - |
AIStockmoo Score
| Analyst Consensus | 0.0 |
| Insider Activity | NA |
| Price Volatility | 0.5 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | 2.0 |
| Average | 0.63 |
|
Agape ATP Corp through its subsidiaries is engaged in providing health and wellness products and health solution advisory services. The principal activities of the company are to supply high-quality health and wellness products, including a supplement to assist in cell metabolism, detoxification, blood circulation, anti-aging and products designed to improve the overall health system in a body. Its product portfolio includes ATP1s Survivor Select, ATP2 Energized Mineral Concentrate, ATP3 Ionized Cal-Mag, ATP4 Omega Blend, AGN-Vege Fruit Fiber and Others. |
|
| Sector | Consumer Defensive |
| Industry | Packaged Foods |
| Investment Style | Small Growth |
| % Held by Insiders | 25.47% |
| % Held by Institutions | 0.74% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Ep Wealth Advisors, Llc | 30 Sep 2024 | 0 |
| Date | Type | Details |
|---|---|---|
| 29 Nov 2024 | Announcement | ATPC Expands Global Market Footprint to Spearhead Medical Innovation with MoUs in Indonesia |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |